Skip to main content
XT logo
XT
(NASDAQ)
iShares Future Exponential Technologies ETF
$82.38-- (--)
Loading... - Market loading

XT ETF: iShares Future Exponential Technologies ETF - Price, Holdings & Analysis

iShares Future Exponential Technologies ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$82.15 - $82.60
52-Week High$84.23
52-Week Low$65.47
Open$82.33
Volume46.73K
Average Volume (3M)72.78K
Assets (AUM)3.81B
Expense Ratio0.46%
Total Holdings223
Inception DateMar 19, 2015
1 Day Change-0.38%
1 Month Change-0.56%
6 Month Change18.17%
YTD Change17.33%
1 Year Change18.19%
52-Week Change19.52%
5 Year Change25.08%
10 Year Change213.34%
50-Day MA$81.62
200-Day MA$75.93
RSI51.38
Stochastic %K46.43
Stochastic %D40.70
Annual Dividend$5.90
Dividend Yield7.16%
Last Dividend Ex-DateDec 19, 2026
Dividend Growth YoY1234.62%
Years Dividend Growth2

Frequently Asked Questions About iShares Future Exponential Technologies ETF

What is the current price of XT?

The latest XT price is $82.38. The 52-week range is $65.47–$84.23. XT has returned 19.5% over the past 52 weeks.

What is the expense ratio for XT?

XT's annual expense ratio is 0.46%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.

Does XT pay dividends?

Yes, XT pays a 7.16% dividend yield. The last ex-dividend date was 2026-12-19. View full dividend history in the Dividends section.

What are the top holdings of XT?

XT's largest holdings are Eli Lilly and Company (4.2%), NVIDIA Corporation (4.1%), Texas Instruments Incorporated (4.0%) (combined weight: 12.2%). The fund holds 223 total positions. View the complete portfolio breakdown in the Holdings section.

How does XT compare to similar ETFs?

Compare XT (0.46% expense ratio, $3.81B AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.